BAUSCH HEALTH COMPANIES INC.

(BHC)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
6.010 USD   -3.06%
08/11Toronto market closes up at 2-month high as oil prices rally
RE
08/11Bausch Health Says it Will Appeal Xifaxan Patent Decision; Shares Rise
MT
08/11TSX extends gains on strong Canada Goose earnings
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Toronto Stocks Sharply Higher; Bausch Health Rises After Chairman Papa Resignation, Paulson Appointment

06/24/2022 | 12:21pm EDT

By Adriano Marchese


Stocks in Toronto were sharply higher midday Friday, in step with global markets, with all Canadian sectors higher led by health technology and energy. Shares in Bausch Health Cos. rose after the company said Chairman Joseph Papa resigned from the board of directors, effective immediately.

Canada's S&P/TSX Composite Index was up 1.8% at 19060.14 and the blue-chip S&P/TSX 60 rose by 1.7% to 1158.49.

Bausch Health shares were 17% higher at C$11.05 after it said after markets closed Thursday that John Paulson was appointed to the board to fill the vacancy and will serve as chairman.


Other market movers:

Shares in Argonaut Gold Inc. fell 7.9% to C$0.53 after the company said it is seeking an exemption from shareholder approval to raise 195 million Canadian dollars, or US$150 million, by way of a marketed offering of its shares that could lead to its delisting from the Toronto Stock Exchange.


Write to Adriano Marchese at adriano.marchese@wsj.com


(END) Dow Jones Newswires

06-24-22 1220ET

Stocks mentioned in the article
ChangeLast1st jan.
ARGONAUT GOLD INC. 3.70% 0.56 Delayed Quote.-76.67%
BAUSCH HEALTH COMPANIES INC. -3.06% 6.01 Delayed Quote.-78.23%
GOLD -1.37% 1774.2 Delayed Quote.-1.49%
All news about BAUSCH HEALTH COMPANIES INC.
08/11Toronto market closes up at 2-month high as oil prices rally
RE
08/11Bausch Health Says it Will Appeal Xifaxan Patent Decision; Shares Rise
MT
08/11TSX extends gains on strong Canada Goose earnings
RE
08/11Bausch Health Companies Inc. - Salix Supports CMS Announcement of First ICD-10 Code for..
AQ
08/10MT NEWSWIRES CANADA OVERNIGHT STOCKS : Avino Silver & Gold; Fortuna; Pan American Silver C..
MT
08/10BAUSCH HEALTH COMPANY BRIEF : To Appeal XIFAXAN Patent Decision to U.S. Court of Appeals f..
MT
08/10Stifel Nicolaus Adjusts Price Target for Bausch Health Companies to $15 From $40, Maint..
MT
08/10BMO Capital Reviews Bausch Health's Q2
MT
08/10RBC Capital Reviews Bausch Health's Q2, Trims Target to US$4.50
MT
08/10BMO Capital Lowers Bausch Health Companies' Price Target to $8 From $15, Maintains Mark..
MT
More news
Analyst Recommendations on BAUSCH HEALTH COMPANIES INC.
More recommendations
Financials (USD)
Sales 2022 8 143 M - -
Net income 2022 -118 M - -
Net Debt 2022 18 907 M - -
P/E ratio 2022 -18,5x
Yield 2022 -
Capitalization 2 174 M 2 174 M -
EV / Sales 2022 2,59x
EV / Sales 2023 2,43x
Nbr of Employees 19 600
Free-Float 95,6%
Chart BAUSCH HEALTH COMPANIES INC.
Duration : Period :
Bausch Health Companies Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAUSCH HEALTH COMPANIES INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 6,01 $
Average target price 13,25 $
Spread / Average Target 120%
EPS Revisions
Managers and Directors
Thomas J. Appio Chief Executive Officer & Director
John Alfred Paulson Chairman
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
Thomas Warren Ross Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BAUSCH HEALTH COMPANIES INC.-78.23%2 174
JOHNSON & JOHNSON-3.37%434 603
ELI LILLY AND COMPANY11.53%292 730
PFIZER, INC.-15.14%281 235
ROCHE HOLDING AG-16.91%275 562
ABBVIE INC.5.32%252 131